Device Trial Radar · NCT04999423
LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment
Last checked: Nov 20, 2026Latest source record: Jan 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
206
Actual
Start
Jan 14, 2022
Primary completion
Mar 1, 2025
Study completion Dec 1, 2026
Sponsor
- Lead sponsor
- Microvention-Terumo, Inc.Public (4543.T)
- Sponsor type
- Industry
- First posted
- Aug 10, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective multicenter international single-arm observational study to demonstrate that use of stent-assisted coiling with LVIS™ Evo™ and HydroCoil® Embolic System (HES) in intracranial aneurysm treatment is effective and safe when assessed at 1 year after the procedure
Conditions
- Intracranial Aneurysm
Interventions
LVIS EVO and HydroCoil Embolic SystemDevice
Stent assisted Coiling
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of aneurysms with complete occlusionTime frame: 12 ± 6-month
Locations
19 sites in 5 countries. Site status is shown where the registry gives one.
Charleroi University Hospital
Charleroi, Belgium
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.